Nanexa AB is a drug delivery company that focuses on the development of PharmaShell®, a new and pioneering drug delivery system that is considered to have great potential in a number of substance types and indication areas. Within the framework of PharmaShell®, Nanexa develops its own projects and has collaborative agreements with several pharmaceutical companies, including AstraZeneca.
| Website | https://www.nanexa.com/ |
| Revenue | $7.1 million |
| Employees | 26 (16 on RocketReach) |
| Founded | 2007 |
| Phone | +46 18 10 03 00 |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Business Services General, Business Services |
| Keywords | Drug Delivery, Drug Delivery Systems, Pharmaceutical Development, Drug Delivery Technology, Biotechnology, Drug Formulation, New Drug Delivery, Innovative Drug Delivery, Pharmaceutical Technology, Advanced Drug Delivery, Delivery Systems, Pharma Tech, Targeted Drug Delivery, Therapeutic Delivery, Bioscience, Nanotechnology, Controlled Release, Nanomedicine |
| Competitors | AstraZeneca, Pfizer, Moderna Therapeutics, Sanofi, Novartis, Merck & Co., Inc., Johnson & Johnson, Roche, Bristol Myers Squibb, GSK +51 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 874 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 5416 Companies, NAICS Code 54161 Companies, NAICS Code 541611 Companies, NAICS Code 54 Companies |
Looking for a particular Nanexa AB employee's phone or email?
The Nanexa AB annual revenue was $7.1 million in 2026.
Bridget Lacey is the Chief Business Officer of Nanexa AB.
16 people are employed at Nanexa AB.
The NAICS codes for Nanexa AB are [541, 5416, 54161, 541611, 54].
The SIC codes for Nanexa AB are [87, 874].